What is emerging today in our device armamentarium that offers another approach in INR treatment?

Flow diversion has been with us for a while – and it’s here to stay – so explains Dr. Saleh LAMIN as he speaks with LINNC online from LINNC Paris 2021.
 
Flow diversion remains a good choice for treating, for instance, sidewall aneurysms in the carotid, but what is emerging in our armamentarium that offers another approach today, especially as we go further distally and into smaller vessels?
 
Today, intrasaccular devices, such as the WEB or CONTOUR have proven themselves in both the acute and elective settings. They are seen to be fast and easy to use with less radiation exposure; and while there is some complication involved in sizing, improved imaging and experience is helping.
So, how do you choose between flow diversion, flow diversion and coiling or one of these newer intrasaccular devices?
 
Dr. LAMIN offers several key elements involved in decision-making:
- Location of the aneurysm: for example; carotid, below the syphon, wide-neck aneurysms or middle or anterior cerebral aneurysms
- Size,
- Or the ability to put the patient under dual antiplatelet therapy.
 
Speaking briefly about recurrence, how to minimize or manage it, Dr. LAMIN then turns to unmet needs and what is really missing today.
Newer antiplatelet therapies, devices or trials – like the one he is involved with, the COATING TRIAL, which is looking at single vs dual antiplatelet therapy with “coated” flow diverters is one response,  but ultimately, he explains, improved training and experience, live meetings like LINNC Paris are in themselves an excellent way to reduce complications and improve care by sharing experience.

 

Learn why, by watching Dr. Saleh LAMIN here….

INTERVIEW

How has the role of surgery evolved with the development of endovascular techniques?

INTERVIEW

What are the current and future trends in stroke treatment?

INTERVIEW

How do robotic procedures work in real life?

INTERVIEW

Discussing the expansion of INR tools available today and the first-in-man experience with the PEGASUS HPC stent system…

INTERVIEW

Interview of Prof. Tudor G. Jovin at LINNC Paris 2021